Detection of somatic mutations in saliva of patients with oral cavity squamous cell carcinoma.

Abstract

6562 Background: Oral cavity squamous cell carcinoma (OCSCC) frequently presents as clinically advanced disease with poor prognosis. When diagnosed at early stages, survival rates approach 80%, underscoring the need for validated, cost-effective detection methods. OCSCC is driven by the serial acquisition of genetic alterations. Tumor-defining somatic mutations are attractive biomarkers and hence their presence in saliva may be associated with malignancy as shown in a few proof-of-concept studies, including our previous work. Based on this premise, we present a low-cost, accurate, next generation sequencing (NGS) test with high clinical utility aimed at detecting mutations in the saliva for early diagnosis and potential screening of OCSCC. Methods: We have designed a custom NGS panel that covers exons of 7 most frequently mutated genes in OSCC. This minimal gene set derived from the analysis from 3 public datasets, predicted incidence of at least one somatic aberration in 89% of patients. We recruited 91 treatment-naïve OCSCC patients and profiled DNA from tissue and matched pre-operative saliva using this test. We also tested DNA from 12 subjects with premalignant lesions with high-grade oral dysplasia and matched saliva. Results: Using stringent variant calling criteria, at least one somatic variant was detected in 88 (96%) of the 91 primary tumors. 90.9% of the matched saliva were concordant, with only a minor decrease in early stage disease. Tumor-specific mutations (≥5% AF) in driver genes were detected in 10 (83.3%) dysplastic lesions, suggesting that driving clonal events may occur early in disease development. Interestingly, in 3 matched saliva of the dysplastic samples, the same mutations were detected. To ensure a variant is not a false positive call, we performed a vigorous multistep analytical validation of this saliva-based test: (i) independent re-sequencing of 24 saliva confirmed 94% reproducibility; (ii) no functionally relevant variants were detected in saliva from 12 of 13 healthy subjects without history of tobacco and alcohol usage; (iii) reproducibility, sensitivity, and specificity were confirmed using a positive control with 7 loci at 0.25% AF across 8 independent saliva sequencing runs and a certified negative control and was found to be on par with droplet digital PCR. Conclusions: These data highlight the feasibility of saliva-based testing for early diagnosis of OCSCC and premalignant lesions.

Mesenchymal Stem Cells Functionalized Sonodynamic Treatment for Improving Therapeutic Efficacy and Compliance of Orthotopic Oral Cancer

“…Oral squamous cell carcinoma (OSCC) is a unique type of cancer that develops in the tissues of the mouth, tongue, and lips, and has been identified as one of the most common malignancy worldwide. [ 1 ] Although various treatment options are available for OSCC, such as surgery, radiotherapy, and chemotherapy, [ 2 ] their therapeutic potential has been limited due to high risk of tissue damages, systemic toxicity, and low therapeutic effects, leading to an average five‐year survival rate below 60%. [ 3 ] Particularly, conventional anticancer therapy always induces severe oral disabilities and malfunctions, [ 4 ] such as eating, tasting, and speaking, and sometimes even induced unwanted facial disfigurement, which profoundly influence fundamental activities and life quality of survivors’ daily life.…”

ανβ3 integrin-targeted ICG-derived probes for imaging-guided surgery and photothermal therapy of oral cancer

“…As a severe life-threatening disease, oral cancer that can seriously affect the functions of the mouth, lips, gums, tongue, and throat [1][2][3] is usually diagnosed at a very late stage, leading to poor prognosis and high mortality rate. [4][5][6] Traditional clinical diagnosis is mainly dependent on pathological biopsy, which is highly invasive, time-consuming and tedious.…”

Charge-reversal nanomedicine based on black phosphorus for the development of A Novel photothermal therapy of oral cancer

“…Oral cancer is one of the most common malignant tumors in the head and neck, and the number of patients with oral cancer has increased dramatically in recent years (Izumchenko et al., 2020 ). At present, clinical treatment is mainly based on surgery (Marcazzan et al., 2018 ).…”